A Perspective on Transplantation Therapy and Stem Cells for Parkinson's Disease

Cell Transplantation

Volumn 13, Issue 3, 2004, Pages 319-327

  Freed, William J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

BRAIN FUNCTION; CELL SURVIVAL; CIRCLING BEHAVIOR; DOPAMINERGIC NERVE CELL; GENE TARGETING; HUMAN; NERVE TRANSPLANTATION; NONHUMAN; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; SCIENCE; STEM CELL; STEM CELL TRANSPLANTATION; TECHNOLOGY;

EID: 2442446319     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000004783984025     Document Type: Note

References (66)

1. Baker, K. A.; Sadi, D.; Hong, M.; Mendez, I. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: Role of the intranigral graft. J. Comp. Neurol. 426(1):106-116; 2000.
2. Baker, K. A.; Purdy, M. B.; Sadi, D.; Mukhida, K.; Mendez, I. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: Implications for graft survival and targeting. Cell Transplant. 11(3):185-193; 2002.
3. Barberi, T.; Klivenyi, P.; Calingasan, N. Y.; Lee, H.; Kawamata, H.; Loonam, K.; Perrier, A. L.; Bruses, J.; Rubio, M. E.; Topf, N.; Tabar, V.; Harrison, N. L.; Beal, M. F.; Moore, M. A.; Studer, L. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 21(10):1200-1207; 2003.
4. Bensadoun, J. C.; Pereira de Almeida, L.; Fine, E. G.; Tseng, J. L.; Deglon, N.; Aebischer, P. Comparative study of GDNF delivery systems for the CNS: Polymer rods, encapsulated cells, and lentiviral vectors. J. Control Release 87(1-3):107-115; 2003.
5. Björklund, A.; Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177(3): 555-560; 1979.
6. Björklund, A.; Dunnett, S. B.; Stenevi, U.; Lewis, M. E.; Iversen, S. D. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199(2):307-333; 1980.
7. Björklund, A.; Schmidt, R. H.; Stenevi, U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res. 212(1):39-45; 1980.
8. Björklund, L. M.; Sanchez-Pernaute, R.; Chung, S.; Andersson, T.; Chen, I. Y.; McNaught, K. S.; Brownell, A. L.; Jenkins, B. G.; Wahlestedt, C.; Kim, K. S.; Isacson, O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 99(4):2344-2349; 2002.
9. Bohn, M. C. A commentary on glial cell line-derived neurotrophic factor (GDNF). From a glial secreted molecule to gene therapy. Biochem. Pharmacol. 57(2):135-142; 1999.
10. Cenci, M. A.; Whishaw, I. Q.; Schallert, T. Animal models of neurological deficits: How relevant is the rat? Nat. Rev. Neurosci. 3(7):574-579; 2002.
11. Choi-Lundberg, D. L.; Lin, Q.; Chang, Y. N.; Chiang, Y. L.; Hay, C. M.; Mohajeri, H.; Davidson, B. L.; Bohn, M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275(5301):838-841; 1997.
12. Choi-Lundberg, D. L.; Lin, Q.; Schallert, T.; Crippens, D.; Davidson, B. L.; Chang, Y. N.; Chiang, Y. L.; Qian, J.; Bardwaj, L.; Bohn, M. C. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp. Neurol. 154(2):261-75; 1998.
13. Collier, T. J.; Sortwell, C. E.; Elsworth, J. D.; Taylor, J. R.; Roth, R. H.; Sladek, J. R., Jr.; Redmond, D. E., Jr. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: Feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J. Comp. Neurol. 442(4):320-330; 2002.
14. Dunnett, S. B.; Björklund, A.; Stenevi, U.; Iversen, S. D. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions. Brain Res. 215(1-2):147-161; 1981.
15. Eslamboli, A.; Cummings, R. M.; Ridley, R. M.; Baker, H. F.; Muzyczka, N.; Burger, C.; Mandel, R. J.; Kirik, D.; Annett, L. E. Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus). Exp. Neurol. 184(1):536-548; 2003.
16. Flax, J. D.; Aurora, S.; Yang, C.; Simonin, C.; Wills, A. M.; Billinghurst, L. L.; Jendoubi, M.; Sidman, R. L.; Wolfe, J. H.; Kim, S. U.; Snyder, E. Y. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16(11):1033-1039; 1998.
17. Freed, W. J.; Perlow, M. J.; Karoum, F.; Seiger, A. Olson, L.; Hoffer, B. J.; Wyatt, R. J. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: Long-term behavioral, biochemical, and histochemical studies. Ann. Neurol. 8(5):510-519; 1980.
18. Freed, W. J. Functional brain tissue transplantation: Reversal of lesion-induced rotation by intraventricular substantia nigra and adrenal medulla grafts, with a note on intracranial retinal grafts. Biol. Psychiatry 18(11):1205-1267; 1983.
19. Freed, W. J.; Ko, G. N.; Niehoff, D. L.; Kuhar, M. J.; Hoffer, B. J.; Olson, L.; Cannon-Spoor, H. E.; Morihisa, J. M.; Wyatt, R. J. Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra. Science 222(4626):937-939; 1983.
20. Freed, W. J.; Cannon-Spoor, H. E.; Wyatt, R. J. Embryonic brain grafts in an animal model of Parkinson's disease. Criteria for human application. Appl. Neurophysiol. 47(1-2):16-22; 1984.
21. Freed, W. J.; Cannon-Spoor, H. E. Cortical lesions increase reinnervation of the dorsal striatum by substantia nigra grafts. Brain Res. 446(1):133-143; 1988.
22. Freed, W. J. Neural transplantation: An introduction. Cambridge, MA: MIT Press; 2000.
23. Hagell, P.; Brundin, P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J. Neuropathol. Exp. Neurol. 60(8):741-752; 2001.
24. Hansson, O.; Castilho, R. F.; Kaminski Schierle, G. S.; Karlsson, J.; Nicotera, P.; Leist, M.; Brundin, P. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp. Neurol. 164(1):102-111; 2000.
25. Johnson, R. E.; Schallert, T.; Becker, J. B. Akinesia and postural abnormality after unilateral dopamine depletion. Behav. Brain Res. 104(1-2):189-196; 1999.
26. Johnston, R. E.; Becker, J. B. Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson's disease. Behav. Brain Res. 104(1-2): 179-187; 1999.
27. Karlsson, J.; Emgård, M.; Gido, G.; Wieloch, T.; Brundin, P. Increased survival of embryonic nigral neurons when grafted to hypothermic rats. Neuroreport 11(8):1665-1668; 2000.
28. Karlsson, J.; Emgård, M.; Brundin, P. Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants. Brain Res. 955(1-2):268-280; 2002.
29. Kawasaki, H.; Mizuseki, K.; Nishikawa, S.; Kaneko, S.; Kuwana, Y.; Nakanishi, S.; Nishikawa, S. I.; Sasai, Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28(1):31-40; 2000.
30. Kawasaki, H.; Suemori, H.; Mizuseki, K.; Watanabe, K.; Urano, F.; Ichinose, H.; Haruta, M.; Takahashi, M.; Yoshikawa, K.; Nishikawa, S.; Nakatsuji, N.; Sasai, Y. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc. Natl. Acad. Sci. USA 99(3):1580-1585; 2002.
31. Kim, J. H.; Auerbach, J. M.; Rodriguez-Gomez, J. A.; Velasco, I.; Gavin, D.; Lumelsky, N.; Lee, S. H.; Nguyen, J.; Sanchez-Pernaute, R.; Bankiewicz, K.; McKay, R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418(6893):50-56; 2002.
32. Kirik, D.; Georgievska, B.; Burger, C.; Winkler, C.; Muzyczka, N.; Mandel, R. J.; Björklund, A. Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer. Proc. Natl. Acad. Sci. USA 99(7):4708-4713; 2002.
33. Kordower, J. H.; Emborg, M. E.; Bloch, J.; Ma, S. Y.; Chu, Y.; Leventhal, L.; McBride, J.; Chen, E. Y.; Palfi, S.; Roitberg, B. Z.; Brown, W. D.; Holden, J. E.; Pyzalski, R.; Taylor, M. D.; Carvey, P.; Ling, Z.; Trono, D.; Hantraye, P.; Deglon, N.; Aebischer, P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290(5492):767-773; 2000.
34. Kozlowski, D. A.; Connor, B.; Tillerson, J. L.; Schallert, T.; Bohn, M. C. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Exp. Neurol. 166(1): 1-15; 2000.
35. Kozlowski, D. A.; Bremer, E.; Redmond, D. E., Jr.; George, D.; Larson, B.; Bohn, M. C. Quantitative analysis of transgene protein, mRNA, and vector DNA following injection of an adenoviral vector harboring glial cell line-derived neurotrophic factor into the primate caudate nucleus. Mol. Ther. 3(2):256-261; 2001.
36. Love, R. M.; Branton, R. L.; Karlsson, J.; Brundin, P.; Clarke, D. J. Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease. Cell Transplant. 11(7):653-662; 2002.
37. Mandel, R. J.; Rendahl, K. G.; Spratt, S. K.; Snyder, R. O.; Cohen, L. K.; Leff, S. E. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J. Neurosci. 18(11):4271-4284; 1998.
38. Marchionini, D. M.; Collier, T. J.; Camargo, M.; McGuire, S.; Pitzer, M. ; Sortwell, C. E. Interference with anoikis-induced cell death of dopamine neurons: Implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. J. Comp. Neurol. 464(2):172-179; 2003.
39. McLoon, L. K.; Lund, R. D.; McLoon, S. C. Transplantation of reaggregates of embryonic neural retinae to neonatal rat brain: Differentiation and formation of connections. J. Comp. Neurol. 205(2):179-189; 1982.
40. McLoon, S. C.; Lund, R. D. Development of fetal retina, tectum, and cortex transplanted to the superior colliculus of adult rats. J. Comp. Neurol. 217(4):376-389; 1983.
41. Mendez, I.; Sadi, D.; Hong, M. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J. Neurosci. 16(22):7216-7227; 1996.
42. Mendez, I.; Baker, K. A.; Hong, M. Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease. Brain Res. Brain Res. Rev. 32(1):328-339; 2000.
43. Mendez, I.; Dagher, A.; Hong, M.; Gaudet, P.; Weerasinghe, S.; McAlister, V.; King, D.; Desrosiers, J.; Darvesh, S.; Acorn, T.; Robertson, H. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: A pilot study. Report of three cases. J. Neurosurg. 96(3):589-596; 2002.
44. Montoya, C. P.; Campbell-Hope, L. J.; Pemberton, K. D.; Dunnett, S. B. The "staircase test": A measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 36(2-3):219-228; 1991.
45. Morizane, A.; Takahashi, J.; Takagi. Y.; Sasai, Y.; Hashimoto, N. Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell-derived inducing activity. J. Neurosci. Res. 69(6):934-939; 2002.
46. Nikkhah, G.; Cunningham, M. G.; Cenci, M. A.; McKay, R. D.; Björklund, A. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J. Neurosci. 15(5 Pt. 1): 3548-3561; 1995.
47. Nishimura, F.; Yoshikawa, M.; Kanda, S.; Nonaka, M.; Yokota, H.; Shiroi, A.; Nakase, H.; Hirabayashi, H.; Ouji, Y.; Birumachi, J.; Ishizaka, S.; Sakaki, T. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 21(2):171-180; 2003.
48. Paul, G.; Brundin, P. Funding embryonic stem-cell research: Will commerce counteract collaboration? Drug Discovery Today 7(1):22-23; 2002.
49. Perlow, M. J.; Freed, W. J.; Hoffer, B. J.; Seiger, A.; Olson, L.; Wyatt, R. J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204(4393):643-647; 1979.
50. Poltorak, M.; Freed, W. J. Cell adhesion molecules in adrenal medulla grafts: Enhancement of chromaffin cell L1/ Ng-CAM expression and reorganization of extracellular matrix following transplantation. Exp. Neurol. 110(1):73-85; 1990.
51. Poltorak, M.; Shimoda, K.; Freed, W. J. L1 substrate enhances outgrowth of tyrosine hydroxylase-immunoreactive neurites in mesencephalic cell culture. Exp. Neurol. 117(2):176-184; 1992.
52. Poltorak, M.; Herranz, A. S.; Williams, J.; Lauretti, L.; Freed, W. J. Effects of frontal cortical lesions on mouse striatum: Reorganization of cell recognition molecule, glial fiber, and synaptic protein expression in the dorsomedial striatum. J. Neurosci. 13(5):2217-2229; 1993.
53. Ramachandran, A. C.; Bartlett, L. E.; Mendez, I. M. A multiple target neural transplantation strategy for Parkinson's disease. Rev. Neurosci. 13(3):243-56; 2002.
54. Schallert, T.; Hall, S. "Disengage" sensorimotor deficit following apparent recovery from unilateral dopamine depletion. Behav. Brain Res. 30(1):15-24; 1988.
55. Schwarz, S. S.; Freed, W. J. Brain tissue transplantation in neonatal rats prevents a lesion-induced syndrome of adipsia, aphagia and akinesia. Exp. Brain Res. 65(2):449-454; 1987.
56. Sladek, J. R., Jr.; Collier, T. J.; Elsworth, J. D.; Roth, R. H.; Taylor, J. R.; Redmond, D. E., Jr. Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates. Cell Transplant. 7(2):87-96; 1998.
57. Sinclair. S. R.; Fawcett, J. W.; Dunnett, S. B. Dopamine cells in nigral grafts differentiate prior to implantation. Eur. J. Neurosci. 11:4341-4348; 1999.
58. Sortwell, C. E.; Daley. B. F.; Pitzer. M. R.; McGuire, S. O.; Sladek. J. R., Jr.; Collier, T. J. Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death. J. Comp. Neurol. 426(1):143-153; 2000.
59. Sortwell, C. E.; Pitzer, M. R.; Collier, T. J. Time course of apoptotic cell death within mesencephalic cell suspension grafts: Implications for improving grafted dopamine neuron survival. Exp. Neurol. 165(2):268-277; 2000.
60. Takashima, H.; Poltorak, M.; Becker, J. B.; Freed, W. J. Effects of adrenal medulla grafts on plasma catecholamines and rotational behavior. Exp. Neurol. 118(1):24-34; 1992.
61. Takashima, H.; Walker, B. R.; Cannon-Spoor, H. E.; Freed, W. J. Kainic acid lesions increase reafferentation of the striatum by substantia nigra grafts. Brain Res. 621(1):71-78; 1993.
62. Taylor, J. R.; Elsworth, J. D.; Roth, R. H.; Sladek, J. R., Jr.; Collier, T. J.; Redmond, D. E., Jr. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls. Exp. Brain Res. 85(2):335-348; 1991.
63. Taylor, J. R.; Elsworth, J. D.; Sladek, J. R., Jr.; Collier, T. J.; Roth, R. H.; Redmond, D. E., Jr. Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys. Cell Transplant. 4(1):13-26; 1995.
64. Truckenmiller, M. E.; Tornatore, C.; Wright, R. D.; Dillon-Carter, O.; Meiners, S.; Geller, H. M.; Freed, W. J. A truncated SV40 large T antigen lacking the p53 binding domain overcomes p53-induced growth arrest and immortalizes primary mesencephalic cells. Cell Tissue Res. 291(2):175-189; 1998.
65. Whittemore, S. R.; Snyder, E. Y. Physiological relevance and functional potential of central nervous system-derived cell lines. Mol. Neurobiol. 12(1):13-38; 1996.
66. Yandava, B. D.; Billinghurst, L. L.; Snyder, E. Y. "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc. Natl. Acad. Sci. USA 96(12):7029-7034; 1999.